Abstract
Bladder cancer is a heterogeneous disease with a variable natural history. 70% present with NMI tumours (stages Ta, T1, or carcinoma in situ) (Sun and Trinh in Hematol Oncol Clin North Am 29(2):205–18, 2015). 30% present with muscle-invasive disease (T2–4) associated with a high risk of death from distant metastases (Sun and Trinh in Hematol Oncol Clin North Am 29(2):205–18, 2015). This chapter covers introduction to bladder cancer type and therapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Amin MB, McKenney JK, Paner GP, Hansel DE, Grignon DJ, Montironi R, Lin O, Jorda M, Jenkins LC, Soloway M, Epstein JI, Reuter VE. ICUD-EAU international consultation on bladder cancer 2012: pathology. Eur Urol. 2013;63(1):16–35.
Pashos CL, Botteman MF, Laskin BL, Redaelli A. Bladder cancer: epidemiology, diagnosis, and management. Cancer Pract. 2002;10(6):311–22.
Sun M, Trinh QD. Diagnosis and staging of bladder cancer. Hematol Oncol Clin North Am. 2015;29(2):205–18, vii.
Witjes JA, Compérat E, Cowan NC, De Santis M, Gakis G, Lebret T, Ribal MJ, Van der Heijden AG, Sherif A. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol. 2014;65(4):778–92.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Goonewardene, S.S., Persad, R., Motiwala, H., Albala, D. (2020). Introduction to Bladder Cancer Type and Therapy. In: Management of Non-Muscle Invasive Bladder Cancer. Springer, Cham. https://doi.org/10.1007/978-3-030-28646-0_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-28646-0_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-28645-3
Online ISBN: 978-3-030-28646-0
eBook Packages: MedicineMedicine (R0)